Cochrane Abstracts
Second or third additional chemotherapy drug for non‐small cell lung cancer in patients with advanced disease
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Second or Third Additional Chemotherapy Drug for Non‐small Cell Lung Cancer in Patients With Advanced Disease." Cochrane Abstracts, John Wiley & Sons, Inc, 2026. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/434883/all/Second_or_third_additional_chemotherapy_drug_for_non‐small_cell_lung_cancer_in_patients_with_advanced_disease.
Second or third additional chemotherapy drug for non‐small cell lung cancer in patients with advanced disease. Cochrane Abstracts. John Wiley & Sons, Inc; 2026. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434883/all/Second_or_third_additional_chemotherapy_drug_for_non‐small_cell_lung_cancer_in_patients_with_advanced_disease. Accessed February 6, 2026.
Second or third additional chemotherapy drug for non‐small cell lung cancer in patients with advanced disease. (2026). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434883/all/Second_or_third_additional_chemotherapy_drug_for_non‐small_cell_lung_cancer_in_patients_with_advanced_disease
Second or Third Additional Chemotherapy Drug for Non‐small Cell Lung Cancer in Patients With Advanced Disease [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2026. [cited 2026 February 06]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/434883/all/Second_or_third_additional_chemotherapy_drug_for_non‐small_cell_lung_cancer_in_patients_with_advanced_disease.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Second or third additional chemotherapy drug for non‐small cell lung cancer in patients with advanced disease
ID - 434883
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/434883/all/Second_or_third_additional_chemotherapy_drug_for_non‐small_cell_lung_cancer_in_patients_with_advanced_disease
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
